ROSEN, SKILLED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

Rosen Law Firm is urging Unicycive Therapeutics investors to seek counsel before an important deadline in a securities class-action lawsuit. The notice signals ongoing shareholder litigation risk for Unicycive, though the article provides no details on alleged damages, claims, or financial impact.